Literature DB >> 10845105

Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism.

A C Aperia1.   

Abstract

The kidney regulates sodium metabolism with extraordinary precision and sensitivity. This is accomplished by an intricate interaction between signals from extrarenal and intrarenal sources and between anti-natriuretic and natriuretic factors. Dopamine, produced in renal proximal tubule cells, plays a central role in this interactive network. Natriuretic hormones that are released from extrarenal sources, such as atrial natriuretic peptide, mediate some of their effects via renal dopamine receptors. On the level of the tubules, dopamine acts by opposing the effects of anti-natriuretic factors, such as angiotensin II and alpha-adrenergic receptors. Sodium retention leads to an increase in renal dopamine tonus, and the natriuretic effects of dopamine are more prominent under this condition. Inhibition or down-regulation of dopamine receptors significantly attenuates the natriuretic response to salt loading. Renal dopamine is modulated by the supply of filtered L-DOPA and the metabolism of dopamine via catechol-O-methyldopamine. The importance of dopamine as a natriuretic hormone is reflected by its capacity to inhibit the majority of renal tubule sodium transporters. Notably, the activity of Na+, K+ ATPase is inhibited in most tubule segments by dopamine. Recent studies have elucidated many of the signaling pathways for renal dopamine receptors. Novel principles for homologous and heterologous sensitization of dopamine receptors have been detected that may explain some of the interaction between dopamine and other first messengers that modulate renal tubule sodium transport. A broad understanding of the renal dopamine system has become increasingly important, since there is now strong evidence from both clinical and experimental studies that dysregulation of the renal dopamine system plays a role in many forms of multigenetic hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845105     DOI: 10.1146/annurev.physiol.62.1.621

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  68 in total

Review 1.  Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility.

Authors:  A Aperia
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Hormonal-dependent recruitment of Na+,K+-ATPase to the plasmalemma is mediated by PKC beta and modulated by [Na+]i.

Authors:  Claudia E Budu; Riad Efendiev; Angel M Cinelli; Alejandro M Bertorello; Carlos H Pedemonte
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury.

Authors:  Shilin Yang; Bing Yao; Yunfeng Zhou; Huiyong Yin; Ming-Zhi Zhang; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-14

4.  Insulin enhances L-dopa renal proximal tubule uptake: a regulatory mechanism impaired in insulin resistance.

Authors:  Andrea Carranza; Carlos F Mendez; Marta Barontini; Susana Nowicki
Journal:  Pflugers Arch       Date:  2004-02-12       Impact factor: 3.657

5.  Dopamine D2-like receptor-mediated opening of K+ channels in opossum kidney cells.

Authors:  Pedro Gomes; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 6.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

7.  Monoamine Oxidase B in Renal Cell Carcinoma.

Authors:  Ingrid Hodorová; Silvia Rybárová; Peter Solár; Marián Benický; Dušan Rybár; Zuzana Kováčová; Jozef Mihalik
Journal:  Med Sci Monit       Date:  2018-08-04

8.  D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.

Authors:  Chunyu Zeng; Yu Han; Hefei Huang; Changqing Yu; Hongmei Ren; Weibin Shi; Duofen He; Lan Huang; Chengming Yang; Xukai Wang; Lin Zhou; Pedro A Jose
Journal:  J Hypertens       Date:  2009-05       Impact factor: 4.844

9.  Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway.

Authors:  Bing Yao; Raymond C Harris; Ming-Zhi Zhang
Journal:  Hypertension       Date:  2009-09-21       Impact factor: 10.190

10.  Chronic regulation of the renal Na(+)/H(+) exchanger NHE3 by dopamine: translational and posttranslational mechanisms.

Authors:  Ming Chang Hu; Francesca Di Sole; Jianning Zhang; Paul McLeroy; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.